News about Industrial talks

Permira Targets USD 4 Billion Valuation for Cambrex Amid USA Manufacturing Drive

Permira acquired Cambrex in 2019 for approximately USD 2.4 billion. The company now generates about USD 225 million in adjusted annual earnings and operates 14 facilities worldwide, half of which are located in the USA.

Industrial talks | 08/09/2025 | By Darshana |  515

ICMR Licenses Nine Health Tech Innovations at India MedTech Expo 2025

At the India MedTech Expo 2025 in Delhi, ICMR licensed nine breakthrough technologies to industry partners under its Patent Mitra initiative, sealing 17 deals in diagnostics and vaccine development to advance affordable, homegrown healthcare.

Industrial talks | 05/09/2025 | By Dineshwori |  374

GST Reforms Hailed as 'a Decisive Win for Patients and Pharma Players'

Indian drug and medical device manufacturers have welcomed the GST reduction on medical devices and lifesaving drugs, calling it a major step toward improving access and easing treatment costs.

Industrial talks | 04/09/2025 | By Dineshwori |  470

GST Council Slashes Tax on Medical Devices, Lifesaving Drugs

The Council has reduced GST on a wide range of medical apparatus and devices — used for medical, surgical, dental, or veterinary purposes as well as for physical or chemical analysis — from 18 percent to five percent.

Industrial talks | 04/09/2025 | By Dineshwori |  577

Shukra Pharma Wins INR 24.06 Cr MEA-Backed Contract to Supply Medicines and Diagnostic Kits to Afghanistan

Shukra Pharmaceuticals has received a Letter of Award (LoA) from HSCC (India) Ltd. for the supply of medicines and diagnostic kits to Afghanistan.

Industrial talks | 01/09/2025 | By Dineshwori |  235

Vivanza Biosciences Appoints Sarang Bharatbhai Pathak as Additional Director

As Additional Director, Sarang Bharatbhai Pathak will oversee Vivanza’s comprehensive portfolio encompassing sales and marketing, sourcing, deal negotiation, stakeholder relations, operational oversight, strategic leadership, and risk management.

Industrial talks | 30/08/2025 | By Dineshwori |  212

Indoco Remedies Signs Sale and Lease Agreement with OPC Asset Solution

Indoco has signed an agreement with OPC Asset Solution for the sale and subsequent leaseback of certain movable properties at its Waluj Facility in Aurangabad and its AnaCipher Clinical Research Organisation (CRO) in Hyderabad, Telangana.

Industrial talks | 30/08/2025 | By Dineshwori |  295

Harbour BioMed Names Yajie Li as Chief Medical Officer

As Chief Medical Officer (CMO), Yajie Li will be based in Shanghai and report directly to Dr. Jingsong Wang, Founder, Chairman and CEO of Harbour BioMed.

Industrial talks | 25/08/2025 | By Dineshwori |  236

Parexel Names Jim Anthony Chief Commercial Officer and President, Biotech Division

Parexel, a leading global clinical research organization (CRO), has appointed Jim Anthony as chief commercial officer (CCO) and president of Parexel Biotech, expanding his responsibilities to strengthen the company’s customer focus and accelerate growth.

Industrial talks | 22/08/2025 | By Darshana |  401

Eli Lilly Announces Retirement of Anne White, Begins Search for Next Neuroscience Chief

Eli Lilly has announced that Anne White, Executive Vice President and President, Lilly Neuroscience, will retire from the company on December 31, 2025, after three decades of service.

Industrial talks | 21/08/2025 | By Dineshwori |  459